Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01260168 · ClinicalTrials.gov registry record
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
A clinical trial, sponsored by Exact Sciences Corporation.
- Completed
- Registry status
- 435
- Enrollment target
NCT01260168 is a clinical trial that has completed, run by Exact Sciences Corporation. The registered enrollment target is 435 participants.
The verdict
NCT01260168 has completed, sponsored by Exact Sciences Corporation.
- COMPLETED
- Registry status
- 435 participants
- Enrollment target
Study Summary
The objective of this study is to confirm the sensitivity of a stool DNA test for detection of colorectal cancer and pre-cancer. Another objective is to provide anonymous, clinically characterized specimens for a bio-repository for future colorectal cancer-related test development.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 435 participants |
| Start Date | 2010-10 |
| Est. Completion | 2013-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01260168
The ClinicalTrials.gov registry entry for NCT01260168 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 435 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Exact Sciences Corporation, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01260168 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01260168 about?
NCT01260168 is a clinical study titled "Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies". The objective of this study is to confirm the sensitivity of a stool DNA test for detection of colorectal cancer and pre-cancer. Another objective is to provide anonymous, clinically characterized specimens for a bio-repository for future colorectal cancer-related test development.
What is the current status of trial NCT01260168?
This trial is currently completed. The enrollment target is 435 participants. The study started on 2010-10. Estimated completion is 2013-11.
Who is sponsoring clinical trial NCT01260168?
This trial is sponsored by Exact Sciences Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.